Metabolic and therapeutic effects of allopurinol in patients with leukemia and gout
Authors:
- William Ralph VoglerWVWilliam Ralph Vogler
- James Arthur BainJBJames Arthur Bain
- Charles Mason HuguleyCHCharles Mason Huguley
- Henry George PalmerHPHenry George Palmer
- Michael Eugene LowreyMLMichael Eugene Lowrey
- 1 April 1966
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 40 (4) , 548-559
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prevention of Hyperuricemia in Leukemia and LymphomaJAMA, 1965
- Allopurinol in the Treatment of GoutAnnals of Internal Medicine, 1965
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- Uric acid excretion and renal function in the acute hyperuricemia of leukemiaThe American Journal of Medicine, 1964
- Effects of Xanthine Oxidase Inhibitor on Clinical Manifestations and Purine Metabolism in Gout.Annals of Internal Medicine, 1964
- Xanthinuria and HemochromatosisNew England Journal of Medicine, 1964
- Acute Uric Acid NephropathyArchives of internal medicine (1960), 1963
- Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidaseBiochemical Pharmacology, 1963
- THE FATE OF 6‐MERCAPTOPURINE IN MANAnnals of the New York Academy of Sciences, 1954
- Enzymatic Determination of Uric Acid with Detailed DirectionsScandinavian Journal of Clinical and Laboratory Investigation, 1953